Mindful Self-Regulation fMRI Pilot Study
MindfulPCMRI
Mindfulness Influences on Self-Regulation: Mental and Physical Health Implications: Mindful Self-Regulation fMRI Pilot Study
2 other identifiers
interventional
26
1 country
1
Brief Summary
The purpose of this study is to 1) determine whether Mindfulness Training for Primary Care (see study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study") engages self-regulation targets such as emotion regulation, attention, and interoceptive awareness; and 2) changes brain activation in neuroimaging tasks before compared to after the training. Neuroimaging fMRI tasks probe mechanisms related to self-regulation, such as attention/inhibition, emotion regulation, self-compassion, interoception and pain regulation. The study will also look at whether chronic disease self-management and successful engagement of self-report and behavioral self-regulation targets (emotion regulation, attention, and interoceptive awareness) relates to the observed brain activation changes after compared to before the mindfulness intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 16, 2016
CompletedFirst Posted
Study publicly available on registry
November 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedOctober 21, 2021
October 1, 2021
3.8 years
November 16, 2016
October 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Brain activation in regions of interest
Change in brain activation will be measured with functional magnetic resonance imaging (fMRI) during four different tasks: an affective go/nogo regulation task, an interoceptive attention task, a self-compassion task and a pain regulation task. Brain activation will be compared between baseline and Week 8.
8 weeks
Secondary Outcomes (2)
Correlations between brain activation changes and self-regulation measures
8 weeks
Correlations between brain activation changes and chronic disease self-management action plan initiation.
9 weeks
Study Arms (1)
Mindfulness Training for Primary Care
EXPERIMENTALFor intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study". For the Mindfulness Training for Primary Care (MTPC) fMRI - arm, we acquire pre-/post-intervention neuroimaging measures from subjects enrolled in this additional pilot fMRI study.
Interventions
For intervention description see Mindfulness Training for Primary Care (MTPC) in the study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study"
Eligibility Criteria
You may qualify if:
- Adults 21-60 years old enrolled for participation in the MINDFUL-PC study.
- During baseline visit, patient has a history of either major depressive disorder, dysthymia, or generalized anxiety disorder, OR has current mild to moderate symptoms of depression (score range of 10-28 on DASS-21 Depression subscale) or anxiety (score \>7 on DASS-21 anxiety subscale).
- Participant does not have a substance use disorder nor intoxication at the time of scanning. Participants must report no more than infrequent recreational cannabis use (i.e., no more than two times a month) and must report capacity for abstinence from both cannabis and ethyl alcohol for the 72 hours prior to the scan.
- Normal or corrected-to-normal vision, and correction must be with contact lenses.
- Right-handed as defined by Edinburgh Handedness Inventory.
You may not qualify if:
- Current severe panic disorder, active severe PTSD symptoms, or psychosis.
- Current suicidality OR severe depression as evidenced by a score of 28 or higher on the DASS-21 Depression subscale.
- A history of neurological disease or injury, including a history of seizures or significant head trauma (i.e., extended loss of consciousness, neurological sequelae, or known structural brain lesion), or previous brain surgery.
- Severe skin disease, skin allergies, or multiple reactions to topical preparations, dressings or tapes.
- Current meditation or intense yoga practice or extensive previous experience.
- Participants with vascular disease, such as peripheral vascular disease, varicose veins, or lymphedema, in both lower limbs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cambridge Health Alliancelead
- Martinos Center for Biomedical Imagingcollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- Brown Universitycollaborator
Study Sites (1)
CHA Center for Mindfulness and Compassion
Somerville, Massachusetts, 02143, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zev D Schuman-Olivier, MD
Cambridge Health Alliance
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2016
First Posted
November 25, 2016
Study Start
September 1, 2016
Primary Completion
June 1, 2020
Study Completion
October 1, 2020
Last Updated
October 21, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share